글로벌 조화에 부합하는 국내 의약품 분류체계 개선방안
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 손성호 | - |
dc.contributor.author | 유봉규 | - |
dc.date.available | 2020-02-29T08:43:12Z | - |
dc.date.created | 2020-02-12 | - |
dc.date.issued | 2012-09 | - |
dc.identifier.issn | 1226-6051 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/17112 | - |
dc.description.abstract | The objective of this study was to investigate drug classification system in Korea and other developed countries. Laws and regulations of Korea regarding the system were retrieved from sources posted in Ministry of Government Legislation. We also reviewed previous research reports performed as part of government’s effort to reform the system The system in the foreign countries was retrieved from the official homepage operated by each country’s government. There have been two research funded by Korean government, which strongly suggested that the system should be reformed. However, we found that the system was never reformed and still effective. Drug classification system in US and most western countries consists of two categories, i.e., prescription drugs and non-prescription drugs except UK, which classifies into three categories: Prescription Only Medicines, Pharmacy Medicines, and General Sales List Medicines. Interestingly,in Japan, non-prescription drugs are further classified into three groups: Group 1, 2, and 3. Recently, Ministry of Health and Welfare (MOHW) in Korea proposed a plan to reclassify all the approved drugs according to purportedly rational and scientific criteria. However, the plan does not include reform of the existing laws and regulations,which appears that it is just one-time action rather than a sustainable administration backed up by law. Therefore, it is recommended that Korean MOHW take appropriate action on laws and regulations with regard to the system to meet global harmonization standard. | - |
dc.language | 한국어 | - |
dc.language.iso | ko | - |
dc.publisher | 한국임상약학회 | - |
dc.relation.isPartOf | 한국임상약학회지 | - |
dc.title | 글로벌 조화에 부합하는 국내 의약품 분류체계 개선방안 | - |
dc.title.alternative | New drug classification system in accordance with global harmonization | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 2 | - |
dc.identifier.bibliographicCitation | 한국임상약학회지, v.22, no.3, pp.260 - 267 | - |
dc.identifier.kciid | ART001700724 | - |
dc.description.isOpenAccess | N | - |
dc.citation.endPage | 267 | - |
dc.citation.startPage | 260 | - |
dc.citation.title | 한국임상약학회지 | - |
dc.citation.volume | 22 | - |
dc.citation.number | 3 | - |
dc.contributor.affiliatedAuthor | 유봉규 | - |
dc.subject.keywordAuthor | drug classification system | - |
dc.subject.keywordAuthor | prescription drugs | - |
dc.subject.keywordAuthor | non-prescription drugs | - |
dc.subject.keywordAuthor | classification criteria | - |
dc.subject.keywordAuthor | global harmonization | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.